AKT1 and nasopharyngeal carcinoma: Moreover, addition of liraglutide suppressed the NPC apoptosis, whereas inhibition of the PI3K/Akt pathway by LY294002 counteracted the inhibiting effects of liraglutide in the high-glucose group (P < 0.05) (Figure 2).